Lixte Biotechnology Holdings, Inc. announced that on May 9, 2022, Philip Palmedo informed the company that he did not intend to stand for reelection at the next annual meeting of stockholders of the company. He will continue as a director until the Annual Meeting. Dr. Palmedo has served as a director of the Company since June 30, 2006.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.429 USD | +1.63% | -1.28% | +3.36% |
05-09 | Lixte Biotechnology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-23 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
1st Jan change | Capi. | |
---|---|---|
+3.36% | 5.46M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- LIXT Stock
- News Lixte Biotechnology Holdings, Inc.
- Philip Palmedo Not to Stand for Re-Election as Director of Lixte Biotechnology Holdings, Inc